Futura Medical plc (FRA:GYX)
Germany flag Germany · Delayed Price · Currency is EUR
0.0090
-0.0005 (-5.26%)
At close: Dec 19, 2025

Futura Medical Statistics

Total Valuation

Futura Medical has a market cap or net worth of EUR 7.89 million. The enterprise value is 3.68 million.

Market Cap7.89M
Enterprise Value 3.68M

Important Dates

The last earnings date was Friday, December 12, 2025.

Earnings Date Dec 12, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 581.12M
Shares Outstanding n/a
Shares Change (YoY) +0.70%
Shares Change (QoQ) -0.09%
Owned by Insiders (%) 6.16%
Owned by Institutions (%) 45.29%
Float 530.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.85
PB Ratio 2.22
P/TBV Ratio 2.22
P/FCF Ratio n/a
P/OCF Ratio 14.61
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.50
EV / Sales 0.41
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -7.16

Financial Position

The company has a current ratio of 2.23

Current Ratio 2.23
Quick Ratio 2.11
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -115.97% and return on invested capital (ROIC) is -72.54%.

Return on Equity (ROE) -115.97%
Return on Assets (ROA) -52.66%
Return on Invested Capital (ROIC) -72.54%
Return on Capital Employed (ROCE) -185.87%
Revenue Per Employee 660,510
Profits Per Employee -524,519
Employee Count14
Asset Turnover 1.06
Inventory Turnover 166.31

Taxes

In the past 12 months, Futura Medical has paid 38,305 in taxes.

Income Tax 38,305
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -97.89% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -97.89%
50-Day Moving Average 0.02
200-Day Moving Average 0.07
Relative Strength Index (RSI) 45.29
Average Volume (20 Days) 10,440

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Futura Medical had revenue of EUR 9.25 million and -7.34 million in losses. Loss per share was -0.02.

Revenue9.25M
Gross Profit 5.96M
Operating Income -7.35M
Pretax Income -7.30M
Net Income -7.34M
EBITDA -7.20M
EBIT -7.35M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 4.30 million in cash and n/a in debt, giving a net cash position of 4.30 million.

Cash & Cash Equivalents 4.30M
Total Debt n/a
Net Cash 4.30M
Net Cash Per Share n/a
Equity (Book Value) 3.55M
Book Value Per Share 0.01
Working Capital 3.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 540,416 and capital expenditures -1.05 million, giving a free cash flow of -513,876.

Operating Cash Flow 540,416
Capital Expenditures -1.05M
Free Cash Flow -513,876
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 64.49%, with operating and profit margins of -79.48% and -79.41%.

Gross Margin 64.49%
Operating Margin -79.48%
Pretax Margin -79.00%
Profit Margin -79.41%
EBITDA Margin -77.91%
EBIT Margin -79.48%
FCF Margin n/a

Dividends & Yields

Futura Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.70%
Shareholder Yield -0.70%
Earnings Yield -93.04%
FCF Yield -6.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Futura Medical has an Altman Z-Score of -1.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.31
Piotroski F-Score 2